Bioorganic & Medicinal Chemistry Letters最新文献

筛选
英文 中文
Cyclic vinyl sulfones activate NRF2 to protect from oxidative stress-induced programmed necrosis.
IF 2.5 4区 医学
Bioorganic & Medicinal Chemistry Letters Pub Date : 2024-12-05 DOI: 10.1016/j.bmcl.2024.130058
Pavel Davidovich, Dmitriy Nikolaev, Raniya Khadiullina, Vladislav Gurzhiy, Emil Bulatov
{"title":"Cyclic vinyl sulfones activate NRF2 to protect from oxidative stress-induced programmed necrosis.","authors":"Pavel Davidovich, Dmitriy Nikolaev, Raniya Khadiullina, Vladislav Gurzhiy, Emil Bulatov","doi":"10.1016/j.bmcl.2024.130058","DOIUrl":"10.1016/j.bmcl.2024.130058","url":null,"abstract":"<p><p>The NRF2 transcriptional factor is a member of cellular stress response machinery and is activated in response to oxidative stress caused either by cellular homeostasis imbalance or by environmental challenges. NRF2 levels are stringently controlled by rapid and continuous proteasomal degradation. KEAP1 is a specific NRF2 binding protein that acts as a bridge between NRF2 and the E3 ligase Cullin-3. In this study, we examine model cyclic vinyl sulfone derivatives as potential NRF2 activating probes. Previously, we and other authors have found anti-inflammatory properties of these compounds in in vivo models; however, the mechanism of action remained unknown. Here, we show that the naphthohydroquinone derivative LCB1353 efficiently stabilizes NRF2 protein levels and upregulates its target genes. At low 5-10 µM concentrations LCB1353 protects non-small cell lung cancer H1299 cells from ferroptotic death induced by cytotoxic concentrations of RSL3, reducing cell death from 90 % to 5 %. Thus, we suggest that cyclic vinyl sulfones are promising scaffolds for the design of protective molecules for conditions associated with toxic and inflammatory levels of oxidative stress.</p>","PeriodicalId":256,"journal":{"name":"Bioorganic & Medicinal Chemistry Letters","volume":" ","pages":"130058"},"PeriodicalIF":2.5,"publicationDate":"2024-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142790516","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development and characterization of pyridyl carboxamides as potent and highly selective Nav1.8 inhibitors.
IF 2.5 4区 医学
Bioorganic & Medicinal Chemistry Letters Pub Date : 2024-12-05 DOI: 10.1016/j.bmcl.2024.130059
Michael Poslusney, Glen Ernst, Yifang Huang, Aaron C Gerlach, Mark L Chapman, Sónia Santos, James C Barrow
{"title":"Development and characterization of pyridyl carboxamides as potent and highly selective Na<sub>v</sub>1.8 inhibitors.","authors":"Michael Poslusney, Glen Ernst, Yifang Huang, Aaron C Gerlach, Mark L Chapman, Sónia Santos, James C Barrow","doi":"10.1016/j.bmcl.2024.130059","DOIUrl":"10.1016/j.bmcl.2024.130059","url":null,"abstract":"<p><p>The voltage-gated sodium channel Na<sub>v</sub>1.8 (SCN10A) has strong genetic and pharmacological validation as a potential target for treating acute and chronic pain. While several different chemotypes have been advanced as selective inhibitors, a quinoxaline carboxamide core structure was identified as a particularly attractive core structure due to very high sodium channel subtype selectivity. However, poor solubility and overall ADME properties need to be improved. Scaffold hopping to a central trifluoromethyl pyridine followed by optimization of distal substituents resulted in improved overall properties. Several advanced lead compounds have been identified with excellent potency, selectivity, solubility, and pharmacokinetics. Preliminary mechanism of action studies suggest that this class of compounds are voltage and state independent inhibitors that bind to a novel site on the Na<sub>v</sub>1.8 channel.</p>","PeriodicalId":256,"journal":{"name":"Bioorganic & Medicinal Chemistry Letters","volume":" ","pages":"130059"},"PeriodicalIF":2.5,"publicationDate":"2024-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142790518","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identification of N-phenyl-N-(quinolin-4-yl) amino carboxylic acids as URAT1 inhibitors with hypouricemic effects.
IF 2.5 4区 医学
Bioorganic & Medicinal Chemistry Letters Pub Date : 2024-12-04 DOI: 10.1016/j.bmcl.2024.130053
Xianxin Hou, Mengjie Shao, Lei Zhang, Ying Yang, Zhiyan Xiao
{"title":"Identification of N-phenyl-N-(quinolin-4-yl) amino carboxylic acids as URAT1 inhibitors with hypouricemic effects.","authors":"Xianxin Hou, Mengjie Shao, Lei Zhang, Ying Yang, Zhiyan Xiao","doi":"10.1016/j.bmcl.2024.130053","DOIUrl":"10.1016/j.bmcl.2024.130053","url":null,"abstract":"<p><p>Urate transporter 1 (URAT1) is a therapeutic target for the treatment of hyperuricemia and gout. However, the application of currently marketed URAT1 inhibitors is hampered by insufficient efficacy and poor safety profiles. A series of N-phenyl-N-(quinolin-4-yl) amino carboxylic acids were designed by adopting strategies of molecular hybridization, scaffold hopping, and functional variation. Most compounds showed apparent inhibitory activity against URAT1, and the most active compound 7 exhibited an IC<sub>50</sub> of 0.18 μ M, which was comparable to the clinically available drug benzbromarone (IC<sub>50</sub> = 0.39 μ M). When tested in parallel with benzbromarone, compound 7 showed significant uric acid-lowering effect in a hyperuricemia zebrafish model induced by potassium oxonate and xanthine sodium salt. Compound 7 was also more metabolically stable than benzbromarone in mouse liver microsomes. The results suggested potential therapeutic benefits of these compounds in the treatment of hyperuricemia and gout.</p>","PeriodicalId":256,"journal":{"name":"Bioorganic & Medicinal Chemistry Letters","volume":" ","pages":"130053"},"PeriodicalIF":2.5,"publicationDate":"2024-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142783444","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identification of peptide-based hepatitis B virus capsid inhibitors based on the viral core protein.
IF 2.5 4区 医学
Bioorganic & Medicinal Chemistry Letters Pub Date : 2024-12-04 DOI: 10.1016/j.bmcl.2024.130054
Junko Fujimoto, Kazutoshi Kawahara, Kazuma Takeda, Sayuri Takeo, Kohei Sato, Kenji Nakashima, Nobuyuki Mase, Masaru Yokoyama, Tetsuro Suzuki, Tetsuo Narumi
{"title":"Identification of peptide-based hepatitis B virus capsid inhibitors based on the viral core protein.","authors":"Junko Fujimoto, Kazutoshi Kawahara, Kazuma Takeda, Sayuri Takeo, Kohei Sato, Kenji Nakashima, Nobuyuki Mase, Masaru Yokoyama, Tetsuro Suzuki, Tetsuo Narumi","doi":"10.1016/j.bmcl.2024.130054","DOIUrl":"10.1016/j.bmcl.2024.130054","url":null,"abstract":"<p><p>In this study, we have identified two novel peptides, 19Ac (comprising residues 91-105) and 20Ac (encompassing residues 96-110), from a systematically designed peptide library based on the Hepatitis B virus (HBV) core protein, that inhibit the assembly of HBV capsid. Peptide 20Ac exhibited about twofold the inhibitory potency of 19Ac and proved effective against both standard and morphothiadin (GLS4)-resistant HBV strains. Molecular dynamics simulations revealed that despite their overlapping sequence, 19Ac and 20Ac bonded to different regions of the core protein, thereby inhibiting capsid assembly through distinct mechanisms. These peptides could serve as valuable seed compounds for the further development of HBV capsid inhibitors, including GLS4-resistant strains.</p>","PeriodicalId":256,"journal":{"name":"Bioorganic & Medicinal Chemistry Letters","volume":" ","pages":"130054"},"PeriodicalIF":2.5,"publicationDate":"2024-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142790521","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
5-Fluoro-2'-deoxyuridine as an efficient 19F NMR reporter for G-quadruplex and i-motif structures.
IF 2.5 4区 医学
Bioorganic & Medicinal Chemistry Letters Pub Date : 2024-12-03 DOI: 10.1016/j.bmcl.2024.130060
Bhakti P Rout, Sarupa Roy, Seergazhi G Srivatsan
{"title":"5-Fluoro-2'-deoxyuridine as an efficient <sup>19</sup>F NMR reporter for G-quadruplex and i-motif structures.","authors":"Bhakti P Rout, Sarupa Roy, Seergazhi G Srivatsan","doi":"10.1016/j.bmcl.2024.130060","DOIUrl":"10.1016/j.bmcl.2024.130060","url":null,"abstract":"<p><p>DNA sequences that are composed of multiple G- and C-tracts can potentially form non-canonical structures called G-quadruplex (GQ) or i-motif (iM), respectively. Such sequences are found at the ends of chromosomes (telomeric repeats) and in the promoter region of several genes that cause cancer. Despite extensive studies, distinguishing different GQ and iM topologies is not easy. In this work, we have used one of the conservatively modified nucleoside analogs, namely 5-fluoro-2'-deoxyuridine (FdU) to study different GQ and iM structures of the human telomeric (H-Telo) DNA repeat sequence using <sup>19</sup>F NMR technique. The probe is minimally perturbing and distinguishes different GQ topologies by providing unique <sup>19</sup>F signatures. Our findings suggest that the telomeric repeat assumes hybrid-type GQ structures in intracellular ionic conditions as opposed to a parallel form predicted by using synthetic cellular crowding mimics. Further, with the incorporation of the probe into a C-rich H-Telo DNA ON, we were able to study the transition from iM structure to a random coil structure. Taken together, FdU is a promising probe, which could be used to determine the structure of non-canonical nucleic acid motifs in vitro and potentially in the native cellular environment.</p>","PeriodicalId":256,"journal":{"name":"Bioorganic & Medicinal Chemistry Letters","volume":" ","pages":"130060"},"PeriodicalIF":2.5,"publicationDate":"2024-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142783440","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Synthesis and evaluation of enzyme inhibition by novel TT01001 derivatives as monoamine oxidase B inhibitors.
IF 2.5 4区 医学
Bioorganic & Medicinal Chemistry Letters Pub Date : 2024-12-02 DOI: 10.1016/j.bmcl.2024.130045
Matheus Barbosa Belchior, Riley T Kane, Jason D Huber, Werner J Geldenhuys
{"title":"Synthesis and evaluation of enzyme inhibition by novel TT01001 derivatives as monoamine oxidase B inhibitors.","authors":"Matheus Barbosa Belchior, Riley T Kane, Jason D Huber, Werner J Geldenhuys","doi":"10.1016/j.bmcl.2024.130045","DOIUrl":"10.1016/j.bmcl.2024.130045","url":null,"abstract":"<p><p>Monoamine oxidase (MAO) B is a promising target for treating stroke reperfusion injury, Parkinson's disease as well as other neurodegenerative diseases. Pharmacological inhibitors of this enzyme have demonstrated the ability to modulate critical neurotransmitter levels, decrease damaging reactive oxygen species and neuroinflammation, and improve mitochondrial dysfunction. We identified TT01001 from a pilot screen which showed good potency for inhibiting MAO-B, with a half-maximal inhibitory concentration below 10 μM. In this study, we explored quantitative-structure activity relationships (QSAR) of 60 derivatives of TT01001 evaluated for MAO-B. Approximately half of these 60 compounds showed IC<sub>50</sub> values superior to that of TT01001 (10). Two of the compounds, 37 and 57, displayed improved MAO-B potency and selectivity from MAO-A, with IC<sub>50</sub> values of 270 and 460 nM respectively. The mode of inhibition of was determined to be both competitive and reversible, and both compounds exhibited moderate ability to passively diffuse across biological membranes. These compounds can be offered as-is for subsequent drug development processes, or they can be derivatized further using the structure-activity relationship information found herein.</p>","PeriodicalId":256,"journal":{"name":"Bioorganic & Medicinal Chemistry Letters","volume":" ","pages":"130045"},"PeriodicalIF":2.5,"publicationDate":"2024-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142779089","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pyrazolo-1-carbothioamides as EGR-1-DNA binding disruptors.
IF 2.5 4区 医学
Bioorganic & Medicinal Chemistry Letters Pub Date : 2024-11-30 DOI: 10.1016/j.bmcl.2024.130055
Hyuk Yoon, Seunghyun Ahn, Dongsoo Koh, Yoongho Lim, Euitaek Jung, Jung Kul Lee, Soon Young Shin
{"title":"Pyrazolo-1-carbothioamides as EGR-1-DNA binding disruptors.","authors":"Hyuk Yoon, Seunghyun Ahn, Dongsoo Koh, Yoongho Lim, Euitaek Jung, Jung Kul Lee, Soon Young Shin","doi":"10.1016/j.bmcl.2024.130055","DOIUrl":"10.1016/j.bmcl.2024.130055","url":null,"abstract":"<p><p>Early growth response 1 (EGR-1) is a key transcription factor that boosts the inflammatory response. Therefore, targeting EGR-1 with small-molecule drugs may be a novel strategy for treating inflammatory diseases, such as atopic dermatitis. (E)-2-(2,4-dimethoxy-6-(4-methoxystyryl)phenyl)-3-hydroxy-6-nitro-4H-chromen-4-one (AB1711) was previously found to be an active compound that disrupts EGR-1-DNA binding. Structural modifications were performed to identify compounds with better activity. Seventy compounds with pyrazolo-1-carbothioamide moieties were derived. Fifty-one compounds showed greater disruption of EGR-1 DNA binding than that induced by AB1711. To determine why the compounds tested in this study showed good activity, pharmacophores were derived based on comparativemolecular field and comparative molecularsimilarity index analyses. Of the 70 compounds tested, compound 36, N-(2,4-dimethoxyphenyl)-3-(1-hydroxynaphthalen-2-yl)-5-(2,4,6-trimethoxyphenyl)-4,5-dihydro-1H-pyrazole-1-carbothioamide showed the best activity. The binding mode between EGR-1 and compound 36 was elucidated using in silico docking. Pharmacophores derived from quantitative structure-activity relationships matched well with the results obtained from in silico docking. To determine the role of compound 36 in cells, further experiments, including electrophoretic mobility shift and reverse-transcription polymerase chain reaction assays, were carried out. These findings demonstrated that compound 36 is a good disruptor of EGR-1-DNA binding.</p>","PeriodicalId":256,"journal":{"name":"Bioorganic & Medicinal Chemistry Letters","volume":" ","pages":"130055"},"PeriodicalIF":2.5,"publicationDate":"2024-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142764659","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Brominated chalcones as promising antileishmanial agents
IF 2.5 4区 医学
Bioorganic & Medicinal Chemistry Letters Pub Date : 2024-11-26 DOI: 10.1016/j.bmcl.2024.130042
Tayssa S.A. Barreto , Tamiris A.C. Santos , Audrey R.S.T. Silva , Emmanoel V. Costa , Liciane A. Pinheiro , Roberta P.M. Fernandes , Ricardo Scher , Péricles B. Alves
{"title":"Brominated chalcones as promising antileishmanial agents","authors":"Tayssa S.A. Barreto ,&nbsp;Tamiris A.C. Santos ,&nbsp;Audrey R.S.T. Silva ,&nbsp;Emmanoel V. Costa ,&nbsp;Liciane A. Pinheiro ,&nbsp;Roberta P.M. Fernandes ,&nbsp;Ricardo Scher ,&nbsp;Péricles B. Alves","doi":"10.1016/j.bmcl.2024.130042","DOIUrl":"10.1016/j.bmcl.2024.130042","url":null,"abstract":"<div><div>Leishmaniasis is a group of diseases caused by protozoa of the genus <em>Leishmania</em>. They are considered neglected diseases and are endemic to tropical and subtropical regions, affecting thousands of people annually. Leishmaniasis has a wide global distribution, present on four continents. Various drugs have been used to control leishmaniasis; however, obstacles such as high toxicity to patients and the occurrence of resistance have led to the search for alternatives. Chalcones are α, β-unsaturated ketones that can occur in the secondary metabolism of plants or can be obtained through organic synthesis. In this study, 21 chalcones brominated were synthesized via the Claisen-Schmidt condensation synthesis and characterized by UHRMS and NMR. The biological activity was evaluated for antiprotozoal potential against <em>Leishmania amazonensis</em> and cytotoxicity against L929 fibroblasts. Eighteen chalcones showed viability inhibition rates above 80 % at a concentration of 50 µM. Six chalcones demonstrated IC50 values ranging from 6.33 ± 0.70 µM to 23.95 ± 2.94 µM and maintained 70 % viability in L929 fibroblasts at 50 µM. The (<em>E</em>)-1-(4-bromophenyl)-3-(2,4,5-trimethoxyphenyl)prop-2-en-1-one, with a trimethoxylation at positions 2, 4, and 5 of ring B and a bromine substituent at position 4 of ring A, exhibited the lowest IC50 value (6.33 µM). These results indicate that these brominated chalcones have potential for studies aiming at the development of new drugs for leishmaniasis control.</div></div>","PeriodicalId":256,"journal":{"name":"Bioorganic & Medicinal Chemistry Letters","volume":"116 ","pages":"Article 130042"},"PeriodicalIF":2.5,"publicationDate":"2024-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142749723","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Discovery of a selective and potent inhibitor of c-Jun N-terminal kinase 1 with anti-pulmonary fibrosis effect
IF 2.5 4区 医学
Bioorganic & Medicinal Chemistry Letters Pub Date : 2024-11-26 DOI: 10.1016/j.bmcl.2024.130044
Shuhua Ren , Fengling Liu , Man Chi , Jinfeng Liu , Yi Huang , Weiwei Huang , Wenjing Gu , Yaxia Yuan , Shurong Hou , Xiabin Chen , Lei Ma
{"title":"Discovery of a selective and potent inhibitor of c-Jun N-terminal kinase 1 with anti-pulmonary fibrosis effect","authors":"Shuhua Ren ,&nbsp;Fengling Liu ,&nbsp;Man Chi ,&nbsp;Jinfeng Liu ,&nbsp;Yi Huang ,&nbsp;Weiwei Huang ,&nbsp;Wenjing Gu ,&nbsp;Yaxia Yuan ,&nbsp;Shurong Hou ,&nbsp;Xiabin Chen ,&nbsp;Lei Ma","doi":"10.1016/j.bmcl.2024.130044","DOIUrl":"10.1016/j.bmcl.2024.130044","url":null,"abstract":"<div><div>We synthesized and evaluated a series of derivatives based on the pyrimidine-2,4-diamine scaffold as potential JNK1 inhibitors, incorporating bridging rings and spirocyclic modifications to enhance their inhibitory activity. These compounds were biologically assessed through JNK enzyme inhibition assays and Western Blot analysis. Compounds <strong>13</strong>, <strong>14</strong> and <strong>19</strong> demonstrated significant inhibitory activity at both the enzyme and cellular level compared to the lead compound <strong>1</strong> and clinical candidate <strong>CC-90001</strong>. Notably, <strong>14</strong> exhibited strong inhibitory potency against JNK1 with sub-nanomolar efficacy and suppresses TGF-β-induced epithelial-mesenchymal transition, indicating its potential as a promising candidate for further development as an anti-pulmonary fibrosis agent targeting JNK1.</div></div>","PeriodicalId":256,"journal":{"name":"Bioorganic & Medicinal Chemistry Letters","volume":"116 ","pages":"Article 130044"},"PeriodicalIF":2.5,"publicationDate":"2024-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142745138","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
(E)-3-(3-([1,1'-Biphenyl]-4-yl)-1-phenyl-1H-pyrazol-4-yl)-1-phenylprop-2-en-1-ones inducing reactive oxygen species generation through glutathione depletion.
IF 2.5 4区 医学
Bioorganic & Medicinal Chemistry Letters Pub Date : 2024-11-26 DOI: 10.1016/j.bmcl.2024.130043
Youngshim Lee, Seunghyun Ahn, Euitaek Jung, Yoongho Lim, Dongsoo Koh, Dong-Ho Bae, Soon Young Shin
{"title":"(E)-3-(3-([1,1'-Biphenyl]-4-yl)-1-phenyl-1H-pyrazol-4-yl)-1-phenylprop-2-en-1-ones inducing reactive oxygen species generation through glutathione depletion.","authors":"Youngshim Lee, Seunghyun Ahn, Euitaek Jung, Yoongho Lim, Dongsoo Koh, Dong-Ho Bae, Soon Young Shin","doi":"10.1016/j.bmcl.2024.130043","DOIUrl":"10.1016/j.bmcl.2024.130043","url":null,"abstract":"<p><p>The accumulation of reactive oxygen species (ROS) disrupts reduction-oxidation homeostasis, which can result in damage to cancer cells. To identify the compounds generating ROS, compounds containing Michael acceptors were designed because they are suggested to be critical for ROS elevation via glutathione depletion. Twelve (E)-3-(3-([1,1'-biphenyl]-4-yl)-1-phenyl-1H-pyrazol-4-yl)-1-phenylprop-2-en-1-ones were synthesized and identified using nuclear magnetic resonance spectroscopy and mass spectrometry. Intracellular ROS levels induced by treatment with the compounds were determined using fluorescence microscopy with the oxidant-sensing fluorescent probe 2',7'-dichlorodihydrofluorescein diacetate. We selected compound 9, which showed the highest activity, and performed further biological experiments, including glutathione depletion and apoptosis assays, using MIA PaCa-2 pancreatic cancer cells. Additionally, the reason why the intracellular ROS level by compound 9 was lower than that of menadione used as a control was explained through in silico docking experiments. Our findings suggest that compound 9 has the potential to act as an anticancer agent by inducing ROS generation through the depletion of intracellular glutathione.</p>","PeriodicalId":256,"journal":{"name":"Bioorganic & Medicinal Chemistry Letters","volume":" ","pages":"130043"},"PeriodicalIF":2.5,"publicationDate":"2024-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142749718","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信